Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 1
1999 1
2006 1
2007 4
2008 3
2009 1
2010 5
2011 4
2012 5
2013 4
2014 2
2015 4
2016 3
2017 2
2018 2
2019 3
2020 8
2021 6
2022 7
2023 7
2024 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Copete S, Pastor-Idoate S, García-Arumí J, Zapata MA. Copete S, et al. Among authors: zapata ma. Retina. 2020 Aug;40(8):e38-e39. doi: 10.1097/IAE.0000000000002832. Retina. 2020. PMID: 32349099 No abstract available.
A Randomized Study of Nutritional Supplementation in Patients with Unilateral Wet Age-Related Macular Degeneration.
García-Layana A, Recalde S, Hernandez M, Abraldes MJ, Nascimento J, Hernández-Galilea E, Olmedilla-Alonso B, Escobar-Barranco JJ, Zapata MA, Silva R, Caballero Arredondo M, Lopez-Sabater MC, Mendez-Martínez S, Pardiñas-Barón N, Calvo P, Fernández-Robredo P. García-Layana A, et al. Among authors: zapata ma. Nutrients. 2021 Apr 10;13(4):1253. doi: 10.3390/nu13041253. Nutrients. 2021. PMID: 33920232 Free PMC article. Clinical Trial.
Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration.
Izquierdo-Serra J, Martin-Pinardel R, Moll-Udina A, Bernal-Morales C, Garay-Aramburu G, Sanchez-Monroy J, Arruabarrena C, Fernandez-Hortelano A, Figueroa MS, Abraldes M, Lavid de Los Mozos FJ, Zapata MA, Ruiz-Moreno JM, Broc-Iturralde L, Gonzalez-Guijarro J, Escobar-Barranco JJ, Gallego-Pinazo R, Parrado-Carrillo A, Dotti-Boada M, Alforja S, Figueras-Roca M, Barthelmes D, Gillies MC, Casaroli-Marano RP, Zarranz-Ventura J; Writing Committee of the Fight Retinal Blindness Spain (FRB! Spain) Users Group. Izquierdo-Serra J, et al. Among authors: zapata ma. Ophthalmol Retina. 2024 Apr;8(4):350-359. doi: 10.1016/j.oret.2023.10.022. Epub 2023 Nov 2. Ophthalmol Retina. 2024. PMID: 37924946
Rhegmatogenous retinal detachment treatment guidelines.
García-Arumí J, Martínez-Castillo V, Boixadera A, Blasco H, Marticorena J, Zapata MÁ, Macià C, Badal J, Distéfano L, Rafart JM, Berrocal M, Zambrano A, Ruíz-Moreno JM, Figueroa MS. García-Arumí J, et al. Among authors: zapata ma. Arch Soc Esp Oftalmol. 2013 Jan;88(1):11-35. doi: 10.1016/j.oftal.2011.10.013. Epub 2012 Sep 20. Arch Soc Esp Oftalmol. 2013. PMID: 23414946 Review. English, Spanish.
The impact of artificial intelligence on retinal disease management: Vision Academy retinal expert consensus.
Danese C, Kale AU, Aslam T, Lanzetta P, Barratt J, Chou YB, Eldem B, Eter N, Gale R, Korobelnik JF, Kozak I, Li X, Li X, Loewenstein A, Ruamviboonsuk P, Sakamoto T, Ting DSW, van Wijngaarden P, Waldstein SM, Wong D, Wu L, Zapata MA, Zarranz-Ventura J. Danese C, et al. Among authors: zapata ma. Curr Opin Ophthalmol. 2023 Sep 1;34(5):396-402. doi: 10.1097/ICU.0000000000000980. Epub 2023 Jul 13. Curr Opin Ophthalmol. 2023. PMID: 37326216 Free PMC article. Review.
Myopic choroidal neovascularization.
Ruiz-Moreno JM, López-Gálvez MI, Donate J, Gomez-Ulla F, García-Arumí J, García-Layana A, Sellés I, Reche J, Montero JA, Pazos B, Zapata MA, Pastor JC. Ruiz-Moreno JM, et al. Among authors: zapata ma. Ophthalmology. 2011 Dec;118(12):2521-3. doi: 10.1016/j.ophtha.2011.07.029. Ophthalmology. 2011. PMID: 22136676 Clinical Trial. No abstract available.
Current status and practical considerations of artificial intelligence use in screening and diagnosing retinal diseases: Vision Academy retinal expert consensus.
Chou YB, Kale AU, Lanzetta P, Aslam T, Barratt J, Danese C, Eldem B, Eter N, Gale R, Korobelnik JF, Kozak I, Li X, Li X, Loewenstein A, Ruamviboonsuk P, Sakamoto T, Ting DSW, van Wijngaarden P, Waldstein SM, Wong D, Wu L, Zapata MA, Zarranz-Ventura J. Chou YB, et al. Among authors: zapata ma. Curr Opin Ophthalmol. 2023 Sep 1;34(5):403-413. doi: 10.1097/ICU.0000000000000979. Epub 2023 Jul 13. Curr Opin Ophthalmol. 2023. PMID: 37326222 Free PMC article. Review.
AIROGS: Artificial Intelligence for Robust Glaucoma Screening Challenge.
de Vente C, Vermeer KA, Jaccard N, Wang H, Sun H, Khader F, Truhn D, Aimyshev T, Zhanibekuly Y, Le TD, Galdran A, Ballester MAG, Carneiro G, Devika RG, Sethumadhavan HP, Puthussery D, Liu H, Yang Z, Kondo S, Kasai S, Wang E, Durvasula A, Heras J, Zapata MA, Araujo T, Aresta G, Bogunovic H, Arikan M, Lee YC, Cho HB, Choi YH, Qayyum A, Razzak I, van Ginneken B, Lemij HG, Sanchez CI. de Vente C, et al. Among authors: zapata ma. IEEE Trans Med Imaging. 2024 Jan;43(1):542-557. doi: 10.1109/TMI.2023.3313786. Epub 2024 Jan 2. IEEE Trans Med Imaging. 2024. PMID: 37713220
69 results